CPC A61K 36/185 (2013.01) [A61K 31/015 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/60 (2013.01); A61P 35/00 (2018.01)] | 12 Claims |
1. A composition for treatment of a noncancerous gynecological disorder (NCGD) selected from the group consisting of: endometriosis, an ovarian endometrioma, a deep endometriosis, dysmenorrhea, and fibroids; wherein the composition comprises between 1% and 99% by weight of a cannabis extract (CE) and wherein the CE of the composition comprises:
a. an extract selected from the group consisting of: a full spectrum hemp extract (FSHE), a broad spectrum hemp extract (BSHE), a cannabidiol (CBD) isolate, and combinations thereof;
b. a carrier at between 1% and 99% by weight of the composition;
c. one or more excipients at between 1% and 50% by weight of the composition; and
d. the CE formulated for administration oromucosally and intravaginally as two separate doses.
|